SCHEMBL4407994

SCHEMBL4407994

C[Si](C)(C)c1cccc(-c2ccc(-c3c4ccccc4c(-c4ccc5ccccc5c4)c4ccccc34)cc2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B1 P14061 1/20 0.42
▸ HSD17B2 P37059 1/20 0.42
▸ ESR1 P03372 8/20 0.41
▸ ESR2 Q92731 7/20 0.41
▸ CYP11B1 P15538 2/20 0.41
▸ CYP11B2 P19099 2/20 0.41
▸ CYP17A1 P05093 1/20 0.41
▸ CYP19A1 P11511 1/20 0.41
▸ LPL P06858 1/20 0.39
▸ LIPG Q9Y5X9 1/20 0.39
▸ IKBKB O14920 1/20 0.38
▸ CYP1A2 P05177 3/20 0.38
▸ SMN1; SMN2 Q16637 3/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ HSD17B10 Q99714 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ TP53 P04637 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ CYP3A4 P08684 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL125705 0.91 ESR1 (0.43) HSD17B1HSD17B2ESR1ESR2CYP11B1
SCHEMBL124687 0.91 ESR1 (0.43) HSD17B1HSD17B2ESR1ESR2CYP11B1
SCHEMBL13820757 0.90 ESR1 (0.36) HSD17B1HSD17B2ESR1ESR2CYP11B1
SCHEMBL13820682 0.90 ESR1 (0.36) HSD17B1HSD17B2ESR1ESR2CYP11B1
SCHEMBL16521361 0.90 HSD17B1 (0.41) HSD17B1HSD17B2ESR1ESR2CYP11B1
SCHEMBL20110000 0.90 HSD17B1 (0.44) HSD17B1HSD17B2ESR1ESR2CYP11B1
SCHEMBL13697096 0.90 HSD17B1 (0.44) HSD17B1HSD17B2ESR1ESR2CYP11B1
SCHEMBL13697091 0.90 HSD17B1 (0.44) HSD17B1HSD17B2ESR1ESR2CYP11B1
SCHEMBL23027127 0.89 ESR1 (0.39) HSD17B1HSD17B2ESR1ESR2CYP11B1
SCHEMBL12200681 0.88 ACHE (0.37) ESR1ESR2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11189809-B2 Organic EL device and display unit SONY CORPORATION (JP) 2021-11-30 — — US disclosed
US-20170271609-A1 ORGANIC EL DEVICE AND DISPLAY UNIT SONY CORPORATION (JP) 2017-09-21 — — US disclosed
US-20170271609-A1 ORGANIC EL DEVICE AND DISPLAY UNIT SONY CORPORATION (JP) 2017-09-21 — — US disclosed
US-9257663-B2 Organic electroluminescent element and display device SONY CORPORATION (JP) 2016-02-09 — — US disclosed
US-20150171356-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND DISPLAY DEVICE MAGNOLIA BLUE CORPORATION (JP) 2015-06-18 — — US disclosed
US-8586202-B2 Organic electroluminescent device and display device SONY CORPORATION (JP) 2013-11-19 — — US disclosed
US-8530062-B2 Organic electroluminescent element and display SONY CORPORATION (JP) 2013-09-10 — — US disclosed
US-8530062-B2 Organic electroluminescent element and display SONY CORPORATION (JP) 2013-09-10 — — US disclosed
US-8179035-B2 Selecting white point for OLED devices GLOBAL OLED TECHNOLOGY LLC (US) 2012-05-15 — — US disclosed
US-8174182-B2 Selecting white point for OLED devices GLOBAL OLED TECHNOLOGY LLC (US) 2012-05-08 — — US disclosed
US-7887931-B2 comprises an anode and a cathode and located there-between a light emitting layer containing a light emitting dopant and a host comprising a monoanthracene derivative; improved operational stability GLOBAL OLED TECHNOLOGY LLC (US) 2011-02-15 — — US disclosed
US-20110024736-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND DISPLAY SONY CORPORATION (JP) 2011-02-03 — — US disclosed
US-20100253214-A1 ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY DEVICE SONY CORPORATION (JP) 2010-10-07 — — US disclosed
US-7602119-B2 OLED with magenta and green emissive layers EASTMAN KODAK COMPANY (US) 2009-10-13 — — US disclosed
US-7471041-B2 OLED multicolor displays EASTMAN KODAK COMPANY (US) 2008-12-30 — — US disclosed
US-7439670-B2 Making multicolor OLED displays EASTMAN KODAK COMPANY (US) 2008-10-21 — — US disclosed
US-7436113-B2 Multicolor OLED displays EASTMAN KODAK COMPANY (US) 2008-10-14 — — US disclosed
US-20080093989-A1 SELECTING WHITE POINT FOR OLED DEVICES GLOBAL OLED TECHNOLOGY LLC 2008-04-24 — — US disclosed
US-7252893-B2 Anthracene derivative host having ranges of dopants EASTMAN KODAK COMPANY (US) 2007-08-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11189809-B2 Organic EL device and display unit L1CAM, ESR1, EPHA8 HSD17B1 3060/4885HSD17B2 2271/4885ESR1 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback